Saw Palmetto (Serenoa repens) in Men with Lower Urinary Tract Symptoms: Effects on Urodynamic Parameters and Voiding Symptoms
- 1 June 1998
- Vol. 51 (6) , 1003-1007
- https://doi.org/10.1016/s0090-4295(98)00143-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Comparison of phytotherapy (Permixon®) with finasteride in the treatment of benign prostate hyperplasia: A randomized international study of 1,098 patientsThe Prostate, 1996
- EFFECT OFSERENOA REPENSEXTRACT (PERMIXONR) ON ESTRADIOL/TESTOSTERONE-INDUCED EXPERIMENTAL PROSTATE ENLARGEMENT IN THE RATPharmacological Research, 1996
- The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic HyperplasiaNew England Journal of Medicine, 1996
- Phytotherapy in treatment of benign prostatic hyperplasia: a critical reviewUrology, 1996
- An observational urodynamic evaluation of men with lower urinary tract symptoms treated with doxazosinUrology, 1996
- Placebo-Controlled Evaluation of the Efficacy and Tolerability of Permixon® in Benign Prostatic Hyperplasia after Exclusion of Placebo RespondersClinical Drug Investigation, 1995
- Comparison of finasteride (proscar®), a 5α reductase inhibitor, and various commercial plant extracts in in vitro and in vivo 5α reductase inhibitionThe Prostate, 1993
- A double‐blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia.British Journal of Clinical Pharmacology, 1984
- Inhibition of androgen metabolism and binding by a liposterolic extract of “serenoa repens B” in human foreskin fibroblastsJournal of Steroid Biochemistry, 1984
- Binding of permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostateJournal of Steroid Biochemistry, 1984